IHRD-46 Response Accepted

Clinician Attendance at Post-Mortem Discussions

Recommendation

Where possible, treating clinicians should attend for clinico-pathological discussions at the time of post-mortem examination and thereafter upon request.

Published Evidence Summary
The following publicly available evidence relates to this recommendation:
Government reports this recommendation as delivered. Implementation status based on Department of Health NI Implementation Programme updates..
Sources
Government response (2018-03-01): Accepted Source: https://www.health-ni.gov.uk/topics/ihrd-implementation-programme Text: Guidance issued on clinician attendance at clinico-pathological discussions. Progress update (2024-01-31): Completed Implementation status based on Department of Health NI Implementation Programme updates. Source: https://www.health-ni.gov.uk/topics/ihrd-implementation-programme
How was this evidence gathered?
Evidence searched by baseline-data-v1 on 26 May 2026
Checked data held on this site (government responses, progress updates, independent evidence)
External sources searched: www.health-ni.gov.uk
This recommendation applies across many organisations. The evidence above reflects central policy activity; adoption in individual organisations may vary.
Jurisdiction
Northern Ireland
Response
Accepted
Accepted HSC Trusts
01 Mar 2018

Guidance issued on clinician attendance at clinico-pathological discussions.

Read Full Response
Source
Inquiry Hyponatraemia Inquiry
Report Report of the Inquiry into Hyponatraemia-related Deaths 31 Jan 2018
View Source
Responsible Bodies
HSC Trusts Primary
Themes & Tags
Coroner family information gaps Fragmented NHS record access and information sharing Post-Mortem Clinical Practice
Recommendation age 8.3 yrs
Last formal update 851 days ago